Nachrichten zur Myovant Sciences Ltd. Aktie

Insiderhandel: Chief Medical Officer verkauft Aktien von Myovant Sciences im Wert von 40.421$

Ferreira, Juan Camilo Arjona - Vorstand - Tag der Transaktion: 2022-10-18...…

Insiderhandel: Principal Executive Officer verkauft Aktien von Myovant Sciences im Wert von 281.131$

Marek, David C. - Vorstand - Tag der Transaktion: 2022-10-18...…

Insiderhandel: General Counsel & Corp. Secy. verkauft Aktien von Myovant Sciences im Wert von 48.712$

Lang, Matthew - Vorstand - Tag der Transaktion: 2022-10-18...…

CORRECTION -- Myovant Sciences, Inc.

BASEL, Switzerland, Oct. 14, 2022 (GLOBE NEWSWIRE) -- In a release issued under the headline "Myovant Sciences to…

Myovant Sciences to Host Second Fiscal Quarter 2022 Earnings Conference Call at 5:00 p.m.

BASEL, Switzerland, Oct. 14, 2022 (GLOBE NEWSWIRE) -- Myovant Sciences (NYSE: MYOV), today announced it will host a webcast…

Insiderhandel: General Counsel & Corp. Secy. verkauft Aktien von Myovant Sciences im Wert von 89.768$

Lang, Matthew - Vorstand - Tag der Transaktion: 2022-10-04...…

Myovant Sciences hits 52-week high as observers see higher takeover offer

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Viasat, Myovant rise; Tesla, Twitter fall

NEW YORK (AP) — Tesla Inc., down $22.85 to $242.40....…

Myovant Sciences Rejects $2.5 Billion Takeover. Now What?

Um den gesamten Artikel unter thestreet.com zu lesen, klicken Sie bitte auf die Überschrift...…

Why Myovant Sciences Stock Is Skyrocketing Today

Myovant said "no thanks" to an acquisition offer in hopes to fetch a higher price....…

Pre-market Movers: LiveWire Group, NextPlat, Myovant Sciences, Atlis Motor Vehicles, FingerMotion

ZURICH (dpa-AFX) - The following are some of the stocks making big moves in Mondays pre-market trading (as of 06.55…

Thinking about buying stock in Myovant Sciences, Clovis Oncology, FingerMotion, LogicBio Therapeutics, or Amplify Energy?

NEW YORK, Oct. 3, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for MYOV, CLVS, FNGR, LOGC, and AMPY. To…

Myovant Stock Soars After Rejecting $2.5 Billion Sumitomo Bid

The offer came at a 27% premium to Myovant's previous market price but was below the company's trading highs last…

Stocks making the biggest moves in the premarket: Credit Suisse, Tesla, Myovant Sciences and more

The stocks making the biggest moves in premarket trading include Credit Suisse, Tesla, Myovant Sciences, and more....…

Myovant climbs 32% after rejection of $2.4B buyout offer

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Myovant stock soars after confirming buyout bid, but said it significantly undervalues the company

Shares of Myovant Sciences Ltd. shot up 27.2% in premarket trading Monday toward an 11-month high, after the biopharmaceutical…

Form 8-K Myovant Sciences Ltd. For: Sep 30

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Myovant: NBC-Rakete erhält Buyout-Offerte – und lehnt ab!

Mit der Aktie des jungen Pharma-Unternehmens Myovant Sciences (WKN: A2DFYA) feierten NBC-Mitglieder bereits 2020 mehr als +100% Kursgewinn. Letztes Jahr…

Sumitomo Offers to Buy All of Myovant in Deal Worth $2.5 Billion

Um den gesamten Artikel unter bloomberg.com zu lesen, klicken Sie bitte auf die Überschrift...…

UPDATE 1-Myovant Sciences rejects $2.5 bln takeover bid from Sumitovant, Sumitomo Pharma

... (Reuters) - Myovant Sciences Ltd said on Sunday it rejected a $2.5......…

Myovant Sciences: Sumitovant Biopharma Offer Significantly Undervalues the Company

Myovant Sciences: Sumitovant Biopharma Offer 'Significantly Undervalues the Company'...…

Sumitovant Biopharma, Sumitomo Pharma submit offer to buy Myovant Sciences in $2.5 billion deal

...(Reuters) - Sumitovant Biopharma said on Sunday the company......…

Sumitovant Biopharma, Sumitomo Pharma submit offer to buy Myovant Sciences in $2.5 bln deal

...Oct 2 (Reuters) - Sumitovant Biopharma said on Sunday the company......…

Myovant Sciences Special Committee of Board Confirms Receipt of Preliminary, Non-binding Proposal from Sumitovant Biopharma and Sumitomo Pharma to Acquire Remaining Shares

BASEL, Switzerland, Oct. 02, 2022 (GLOBE NEWSWIRE) -- Myovant Sciences Ltd. (NYSE: MYOV) (the “Company”) confirmed today that…

Sumitovant Biopharma and Sumitomo Pharma Announce Offer to Acquire Outstanding Shares of Myovant Sciences

NEW YORK and TOKYO, Oct. 2, 2022 /PRNewswire/ -- Sumitovant Biopharma Ltd. ("Sumitovant"), in conjunction with parent company Sumitomo Pharma…

dpa-AFX ProFeed